• Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
Friday, March 24, 2023
No Result
View All Result
SUBSCRIBE
The Outlooker
27 °c
Delhi
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
  • Home
  • Opinion
  • Politics
  • World
  • Business
  • Science & Tech
No Result
View All Result
The Outlooker
No Result
View All Result
  • National
  • Politics
  • Opinion
  • Business
  • Science
  • World
  • Health
Home Business

Reiterate ‘top buy’ on Info Edge as sharp recovery anticipated

by The Outlooker Web Desk
June 27, 2021
in Business
0
Reiterate ‘top buy’ on Info Edge as sharp recovery anticipated
1.8k
SHARES
12.9k
VIEWS
Share on FacebookShare on Twitter

Potential for price increases and operating leverage should translate into buoyant EBITDA margins.

Store expansion gathers pace: To our and even management’s surprise, billing increased 40% QoQ despite the panic around the 2nd covid wave beginning March 2021. This was 25% above our estimates and largely driven by the robust volume increase at Naukri. In this backdrop, the company made higher variable pay-outs (~130-140%) to sales team.

In conjunction with partial salary hike and some one-off provisions, reported margins missed our estimates. Key takeaway is the management commentary on recruitment and matrimony segments not seeing any impact even in April and May despite stringent lockdowns. While 99 Acres was impacted, we understand traffic bounced back sharply in June. As highlighted (link), we were anticipating a sharp recovery in white collar hiring activity from H2Fy22 – post the normalisation of 2nd wave. However, the quick pace of recovery & the strong outlook surprised us. Naukri will be a key beneficiary given its near monopoly positioning (80%+ traffic share) in white collar hiring. Potential for price increases and operating leverage should translate into buoyant EBITDA margins. We upgrade FY22-23E EPS by ~5%.

Reiterate Info Edge as TOP BUY idea in our coverage. Impending IPOs of investee firms (Zomato & Policybazaar) should be key catalysts for value unlocking.

In-line revenue; margin miss due to higher variable pay-outs and provisions: Reported revenue was largely in-line with our / street estimates. However, EBITDA margin was lower than our estimates. This was led by (1) higher variable pay-outs to sales team (in the range of 130-140%) in the back drop of stronger than anticipated pick up in billing, (2) partial impact of salary hikes and (3) one-off provisions.

Strong lead indicators; sharp recovery in hiring seems to be at play: Overall billing witnessed a robust increase in Mar-21 (+40% QoQ, 25% YoY and 25% above our expectations) not withstanding the panic around the 2nd wave beginning March. The strength in billings seem to be led by Naukri (+26% YoY), especially on the volume front.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

The Outlooker is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

The Outlooker Web Desk

The Outlooker Web Desk

Next Post
Mayawati Says BSP Will Fight State Elections Alone In Uttar Pradesh, Uttarakhand; Snubs Reports On Tie-Ups

Mayawati Says BSP Will Fight State Elections Alone In Uttar Pradesh, Uttarakhand; Snubs Reports On Tie-Ups

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Johnson and Johnson Loses Key Tuberculosis Drug Patent In India
National

Johnson and Johnson Loses Key Tuberculosis Drug Patent In India

March 24, 2023
Vandalism At Indian High Commission In London Raised In UK Parliament
National

Vandalism At Indian High Commission In London Raised In UK Parliament

March 23, 2023
Rahul Gandhi Can Be Disqualified, Say Congress Sources: 10 Points
National

Rahul Gandhi Can Be Disqualified, Say Congress Sources: 10 Points

March 23, 2023
Opposition Alleges “Conspiracy” As Rahul Gandhi Convicted For Defamation
National

Opposition Alleges “Conspiracy” As Rahul Gandhi Convicted For Defamation

March 23, 2023

Connect with us

No Result
View All Result

Archives

  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020

Category

  • Artistic
  • Business
  • Crypto
  • Design
  • Entertainment
  • Fashion
  • featured
  • Food
  • Gaming
  • Health
  • Human
  • Lifestyle
  • Movie
  • Music
  • National
  • Opinion
  • Politics
  • Science
  • Spaces
  • Sports
  • Tech
  • Travel
  • Uncategorized
  • World

Recent Posts

  • Johnson and Johnson Loses Key Tuberculosis Drug Patent In India
  • Vandalism At Indian High Commission In London Raised In UK Parliament
  • Rahul Gandhi Can Be Disqualified, Say Congress Sources: 10 Points

About Us

The Outlooker

The Outlooker is your source of authentic, hand-picked news, stories, analysis from India & the World.

  • Terms Of Service
  • Privacy Policy
  • About us
  • Submit your story
  • Contact

© 2019-2021 The Outlooker. All rights reserved.

No Result
View All Result
  • Home
  • Politics
  • World
  • Business
  • Science
  • National
  • Entertainment
  • Gaming
  • Movie
  • Music
  • Sports
  • Fashion
  • Lifestyle
  • Travel
  • Tech
  • Health
  • Food

© 2019-2021 The Outlooker. All rights reserved.